Application of prussian blue nanoparticles in preparation of drugs for preventing, delaying or treating nervous system degenerative diseases

A nervous system degenerative and Prussian blue technology, applied in the field of biomedicine, can solve the problems of no relevant reports on the study of nervous system degenerative diseases, achieve the effects of improving learning and memory, increasing the proportion of living cells, and facilitating mass production

Active Publication Date: 2020-08-14
TIANJIN UNIV
View PDF7 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, there are no relevant reports on the application of Prussian blue nanoparticles in the prevention, delay or treatment of neurodegenerative diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of prussian blue nanoparticles in preparation of drugs for preventing, delaying or treating nervous system degenerative diseases
  • Application of prussian blue nanoparticles in preparation of drugs for preventing, delaying or treating nervous system degenerative diseases
  • Application of prussian blue nanoparticles in preparation of drugs for preventing, delaying or treating nervous system degenerative diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] In this example, a Prussian blue nanoparticle without functional modification was prepared. The preparation method includes the following steps:

[0049] (1) Dissolve 0.01 mM potassium ferrocyanide and 0.001 mM m PEG-COOH (MW5000) in 5 mL deionized water, mix well to obtain a clear solution A; dissolve 0.01 mM ferric chloride in 5 mL deionized water, Fully dissolve to obtain clear solution B; add solution B dropwise to solution A, and react at 60°C for 1 hour;

[0050] (2) After the reaction system is lowered to 25°C, react for 1 hour, centrifuge and wash to obtain Prussian blue nanoparticles without functional modification.

[0051] The prepared Prussian blue nanoparticles were characterized by particle size and potential. The result was that the dynamic light scattering particle size was 80nm and the surface potential was -32mV.

Embodiment 2

[0053] In this example, a single-targeted modified Prussian blue nanoparticle was prepared. The preparation method includes the following steps:

[0054] (1) Dissolve 0.01 mM potassium ferrocyanide and 0.001 mM m PEG-COOH (MW5000) in 5 mL deionized water, mix well to obtain a clear solution A; dissolve 0.01 mM ferric chloride in 5 mL deionized water, Fully dissolve to obtain clear solution B; add solution B dropwise to solution A, and react at 60°C for 1 hour;

[0055] (2) After the reaction system is lowered to 25°C, react for 1 hour, centrifuge and wash, to obtain Prussian blue nanoparticles without functional modification;

[0056] (3) Dissolve the obtained Prussian blue nanoparticles, 0.01 mM 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride in 10 mL of deionized water, and react at 25°C for 15 minutes to obtain a solution D;

[0057] (4) Add 0.01mM N-hydroxysuccinimide and 0.4μM Congo red to solution D, react at 25°C for 24h, centrifuge and wash, and the resulting pre...

Embodiment 3

[0060] In this example, a dual-targeted modified Prussian blue nanoparticle was prepared. The preparation method includes the following steps:

[0061] (1) Dissolve 0.01 mM potassium ferrocyanide and 0.001 mM m PEG-COOH (MW5000) in 5 mL deionized water, mix well to obtain a clear solution A; dissolve 0.01 mM ferric chloride in 5 mL deionized water, Fully dissolve to obtain clear solution B; add solution B dropwise to solution A, and react at 60°C for 1 hour;

[0062] (2) After the reaction system is lowered to 25°C, react for 1 hour, centrifuge and wash, to obtain Prussian blue nanoparticles without functional modification;

[0063] (3) Dissolve the obtained Prussian blue nanoparticles, 0.01 mM 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride in 10 mL of deionized water, and react at 25°C for 10 minutes to obtain a solution D;

[0064] (4) Add 0.01mM N-hydroxysuccinimide, 0.005mg transferrin, and 0.5μM Congo red to solution D, react at 25°C for 24h, centrifuge and wash, a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention relates to an application of prussian blue nanoparticles in preparation of drugs for preventing, delaying or treating nervous system degenerative diseases. Researches find that the prussian blue nanoparticles have remarkable effects in the aspects of preventing, delaying or treating nervous system degenerative diseases. Cell level test results show that the prussian blue nanoparticles can reduce the ROS level in nerve cells stimulated by hydrogen peroxide and increase the proportion of living cells in the nerve cells stimulated by hydrogen peroxide; and animal level test resultsshow that the prussian blue nanoparticles can significantly reduce the expression level of oxidative stress markers in hippocampus of nervous system degenerative disease model mice, significantly improve the learning and memory ability of nervous system degenerative disease model mice, and improve dyskinesia. The preparation process of the prussian blue nanoparticles is simple, the macro production is easy, the reaction condition is mild, and the surface modification is easy.

Description

Technical field [0001] The invention belongs to the technical field of biomedicine, and relates to a new application of Prussian blue nanoparticles, in particular to the application of Prussian blue nanoparticles in preparing drugs for preventing, delaying or treating degenerative diseases of the nervous system. Background technique [0002] Nervous system degenerative diseases are irreversible neurological diseases caused by the loss of neurons in the brain and spinal cord. They mainly include Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, etc. With the aging of society, the incidence of degenerative diseases of the nervous system is on the rise, causing huge social medical expenditure and family pressure. Most degenerative diseases of the nervous system still lack effective treatment methods. Therefore, finding effective methods to prevent, delay and treat such diseases is a problem that needs to be solved urgently. [0003] Oxidat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K33/26A61K9/14A61P25/28A61P25/16A61P25/14A61P25/08A61P25/00A61P25/02
CPCA61K33/26A61K9/14A61P25/28A61P25/16A61P25/14A61P25/08A61P25/00A61P25/02A61K47/54A61K9/0019A61K9/0053A61K9/006A61K9/0014A61K9/0043A61K47/6843A61K47/64A61K47/644A61K47/18
Inventor 常津窦妍赵冬菊唐雨晴
Owner TIANJIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap